Drug information on Renodapt-S (Mycophenolic Acid) from Biocon Limited

---

•  Common - Dizziness, stomach pain, vomiting, indigestion, nausea, diarrhea, weight loss, fatal pulmonary fibrosis, constipation, anemia, decrease in white blood cells.

•  Cardiovascular - Rapid heart rate, weak pulse.

•  Respiratory - Rapid and shallow breathing, dry cough, wheezing, shortness of breath, coughing up blood or vomit, inflammation of the esophagus.

•  Genitourinary - Increased urination.

•  Gastrointestinal - Rapid edema (swelling) of the skin, gastric ulcers, duodenal ulcers.

•  General - Lack of sleep.

Adult: Initial dose: 720 mg orally twice a day on an empty stomach, one hour before or two hours after food intake.
Geriatrics: 720 mg twice a day on an empty stomach, one hour before or two hours after food intake.
Pediatric: 400 mg/m² twice a day (up to a maximum of 720 mg twice a day). Pediatric doses for patients with BSA <1.19 m² cannot be accurately administered using currently available formulations of Myfortic tablets.

It comes as a tablet, taken on an empty stomach and administered in combination with cyclosporine and corticosteroids.

Contraindicated in patients with known hypersensitivity, pregnancy and lactation.

• Caution should be exercised in patients with history of active peptic ulcer, blood disorders, severe kidney impairment, polyomavirus infections, gastrointestinal disorders.

• Patient may develop with increased risk of certain types of cancer, if it so consult with your doctor immediately.

• Avoid exposure to sunlight/UV light.

• Women taking this medication should seek contraceptive counseling.

Avoid excess dosage

Store at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly closed container.